Safety and Effectiveness of the Adherus Dural Sealant System When Used as a Dural Sealant in Cranial Procedures
Completed · Phase 3
Conditions studied: Elective Cranial Procedures With Dural Incision
In brief
The purpose of the study is to demonstrate the safety and effectiveness of the Adherus Dural Sealant System when used as a dural sealant in conjunction with standard methods of dural repair in cranial procedures.
Key facts
- Study ID
- NCT01158378
- Run by
- HyperBranch Medical Technology, Inc
- People needed
- 250
- Starts
- 2010-06-01
- Expected to finish
- 2013-01-01
- Last updated by the study team
- 2014-04-08
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Pre-Operative Inclusion Criteria
- Subject is scheduled for an elective cranial procedure involving a dural incision using any of the following surgical locations/approaches (or combination): frontal, temporal, occipital, and parietal (i.e. supratentorial), and/or midline or lateral suboccipital (i.e. infratentorial.) Subject requires a procedure involving a Class 1/clean wound (uninfected surgical wound in which no inflammation is encountered)
- Intra-Operative Inclusion Criteria
- Subject's linear extent of durotomy is ≥2 cm
- Subject's dural margins from the edges of bony defect are ≥3 mm throughout
- Subject's CSF leak is present intra-operatively following completion of primary dural closure (with or without non-autologous duraplasty or autologous tissue), either spontaneously or upon Valsalva maneuver, at up to 20 cm H2O for up to five (5) seconds
You may not qualify if…
- Subject requires a procedure involving a translabyrinthine, transsphenoidal, transoral approach, or any procedure that penetrates the air sinus or mastoid air cells. Note: Superficial penetration of mastoid air cells is not an exclusion if cells are appropriately sealed (e.g. bone wax).
- Subject has a CSF shunt such as; ventriculo-peritoneal, ventriculo-pleural, ventriculo-atrial or lumbo-peritoneal shunts.
- Subject has an external ventricular or lumbar CSF drain that must be left in place after surgery.
- Subject has had radiation treatment to the surgical site, or standard fractionated radiation therapy is planned within ten days post index-procedure. (Note: stereotactic radiosurgery prior to the planned index procedure is not an exclusion criterion).
- Subject has a systemic infection or evidence of any infection near planned operative site.
- Intra-Operative Exclusion Criteria
- Subject has an Incidental finding that meets any pre-operative exclusion criterion listed above.
- Subject requires the intra-operative placement of a CSF diversion device (e.g. ventricular catheter, subdural catheter, lumbar drain, or other device designed to externally evacuate CSF) that will be left in place after the procedure. Note: Subgaleal drains used for acute post-operative management of the incision site are permitted.
Where it is running
- Colorado Brain and Spine Institute/Swedish Medical Center — Englewood, Colorado, United States
- Florida Hospital — Orlando, Florida, United States
- University of South Florida — Tampa, Florida, United States
- Northwestern University — Chicago, Illinois, United States
- Rush University Medical Center — Chicago, Illinois, United States
- NorthShore University HealthSystem — Evanston, Illinois, United States
- Wayne State University — Detroit, Michigan, United States
- Borgess Research Institute — Kalamazoo, Michigan, United States
- Saint Louis University — St Louis, Missouri, United States
- Stony Brook University Medical Center — Stony Brook, New York, United States
- Carolina Neurosurgery & Spine Associates — Charlotte, North Carolina, United States
- Wake Forest School of Medicine — Winston-Salem, North Carolina, United States
- Mayfield Clinic — Cincinnati, Ohio, United States
- Oklahoma Spine and Brain Institute — Tulsa, Oklahoma, United States
- Penn State University Milton S. Hershey Medical Center — Hershey, Pennsylvania, United States
- University of Virginia — Charlottesville, Virginia, United States
- West Virginia University — Morgantown, West Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.